MXC

(2S,3R)-2-[(7-aminocarbonyl-2-methanoyl-indolizin-3-yl)amino]-4-aminocarbonyloxy-3-methyl-3-sulfino-butanoic acid

Created:	2009-01-28
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where MXC is found as a standalone ligand1 entries where MXC is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	47
Chiral Atom Count	3
Bond Count	48
Aromatic Bond Count	10

2D diagram of MXC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S,3R)-2-[(7-aminocarbonyl-2-methanoyl-indolizin-3-yl)amino]-4-aminocarbonyloxy-3-methyl-3-sulfino-butanoic acid
Systematic Name (OpenEye OEToolkits)	(2S,3R)-2-[(7-aminocarbonyl-2-methanoyl-indolizin-3-yl)amino]-4-aminocarbonyloxy-3-methyl-3-sulfino-butanoic acid
Formula	C₁₆ H₁₈ N₄ O₈ S
Molecular Weight	426.401
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(OCC(S(=O)O)(C)C(C(=O)O)Nc2c(cc1cc(ccn12)C(=O)N)C=O)N
SMILES	CACTVS	3.341	C[C](COC(N)=O)([CH](Nc1n2ccc(cc2cc1C=O)C(N)=O)C(O)=O)[S](O)=O
SMILES	OpenEye OEToolkits	1.5.0	CC(COC(=O)N)(C(C(=O)O)Nc1c(cc2n1ccc(c2)C(=O)N)C=O)S(=O)O
Canonical SMILES	CACTVS	3.341	C[C@](COC(N)=O)([C@@H](Nc1n2ccc(cc2cc1C=O)C(N)=O)C(O)=O)[S@@](O)=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C[C@](COC(=O)N)([C@H](C(=O)O)Nc1c(cc2n1ccc(c2)C(=O)N)C=O)[S@](=O)O
InChI	InChI	1.03	InChI=1S/C16H18N4O8S/c1-16(29(26)27,7-28-15(18)25)11(14(23)24)19-13-9(6-21)5-10-4-8(12(17)22)2-3-20(10)13/h2-6,11,19H,7H2,1H3,(H2,17,22)(H2,18,25)(H,23,24)(H,26,27)/t11-,16-/m0/s1
InChIKey	InChI	1.03	WVRCRSIVCWLCEG-ZBEGNZNMSA-N

Related Resource References

Resource Name	Reference
PubChem	49867346

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.